← Browse by Condition
Medical Condition

multiple system atrophy

Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2, EARLY_Phase 1
NCT07197866 Phase 2
Recruiting

An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy

Enrollment
200 pts
Location
United States, Germa...
Sponsor
Teva Branded Pharmaceutical Pr...
View Trial →
NCT06848231 Phase 2
Recruiting

A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy

Enrollment
75 pts
Location
United States, Japan...
Sponsor
Yoda Therapeutics Inc.
View Trial →
NCT06568237 Phase 2
Recruiting

A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy

Enrollment
350 pts
Location
United States, Franc...
Sponsor
Teva Branded Pharmaceutical Pr...
View Trial →
NCT06098612 EARLY_Phase 1
Recruiting

PET Imaging Evaluation of [11C]SY08

Enrollment
40 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT05826457
Recruiting

North American Prodromal Synucleinopathy Consortium Stage 2

Enrollment
500 pts
Location
United States, Canad...
Sponsor
Washington University School o...
View Trial →
NCT01793168
Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Enrollment
20,000 pts
Location
United States, Austr...
Sponsor
Sanford Health
View Trial →